Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PRKDC | P78527 | 5/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453782 | 0.97 | ALOX5 (0.47) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL21454048 | 0.95 | ALOX5 (0.48) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL21453664 | 0.93 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL21453753 | 0.93 | ALOX5 (0.54) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL19541036 | 0.93 | ALOX5 (0.54) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL21453625 | 0.92 | ALOX5 (0.46) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL21454262 | 0.91 | ALOX5 (0.44) | ALOX5PRKDCPARP14 | |
| SCHEMBL16621705 | 0.91 | ALOX5 (0.52) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL16621720 | 0.91 | ALOX5 (0.52) | ALOX5PRKDCPARP14PIK3CDPIK3CB | |
| SCHEMBL16621682 | 0.90 | ALOX5 (0.54) | ALOX5PRKDCPARP14PIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-06-15 | — | — | US | disclosed |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD (CN) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038121-B2 | 9 membered ring carbazole compounds | SLC25A21, OCIAD2, OXA1L | ALOX5 1012/4885PRKDC 4258/4885PARP14 1921/4885 |
| US-20190312214-A1 | 9 MEMBERED RING CARBAZOLE COMPOUNDS | SLC25A21, OCIAD2, OXA1L | ALOX5 1012/4885PRKDC 4258/4885PARP14 1921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.